triamterene has been researched along with Cerebrovascular Disorders in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cioffi, F | 1 |
| Bisiani, M | 1 |
1 other study available for triamterene and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Triamteril-chlorothiazide-reserpine combination in prophylaxis of cerebrovascular accidents in patients with cerebral vascular lesions with elevated arterial hypertension].
Topics: Cerebrovascular Disorders; Chlorothiazide; Humans; Hypertension; Reserpine; Triamterene | 1965 |